© 2001 Journal of Clinical Pathology
Review
The three dimensional structure of the type I insulin-like growth factor receptor
1 CSIRO Health Sciences and Nutrition, Parkville Laboratory, 343 Royal Parade, Parkville, Victoria, 3052, Australia
2 Biomolecular Research Institute, 343 Royal Parade, Parkville, Victoria, 3052, Australia
3 CSIRO Health Sciences and Nutrition, Kintore Avenue, Adelaide, South Australia, 5000, Australia
Correspondence to:
Dr Ward Colin.Ward{at}hsn.csiro.au
Ever since the discovery of insulin and its role in the regulation of glucose metabolism, there has been great interest in the molecule itself, the insulin-like growth factors (IGFs), and their receptors (IR and IGF-R). These receptors form a subfamily of tyrosine kinase receptors which are large, transmembrane proteins consisting of several structural domains. Their ectodomains have a similar arrangement of two homologous domains (L1 and L2) separated by a Cys rich region. The C-terminal half of their ectodomains consists of three fibronectin type 3 repeats, and an insert domain that contains the
ß cleavage site. This review summarises the key developments in the understanding of the structure of this family of receptors and their relation to other multidomain proteins. Data presented will include multiple sequence analyses, single molecule electron microscope images of the IGF-1R, insulin receptor (IR), and IRFab complexes, and the three dimensional structure of the first three domains of the IGF-1R determined to 2.6 Å resolution by x ray crystallography. The L domains each adopt a compact shape consisting of a single stranded, right handed ß-helix. The Cys rich region is composed of eight disulphide bonded modules, seven of which form a rod shaped domain with modules associated in an unusual manner.
Key Words: insulin-like growth factor insulin receptors three dimensional structure electron microscopy
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Inagaki, K., Tiulpakov, A., Rubtsov, P., Sverdlova, P., Peterkova, V., Yakar, S., Terekhov, S., LeRoith, D.
(2007). A Familial Insulin-Like Growth Factor-I Receptor Mutant Leads to Short Stature: Clinical and Biochemical Characterization. J. Clin. Endocrinol. Metab.
92: 1542-1548
[Abstract] [Full Text] -
Blanquart, C., Boute, N., Lacasa, D., Issad, T.
(2005). Monitoring the Activation State of the Insulin-Like Growth Factor-1 Receptor and Its Interaction with Protein Tyrosine Phosphatase 1B Using Bioluminescence Resonance Energy Transfer. Mol. Pharmacol.
68: 885-894
[Abstract] [Full Text] -
Stroud, R. M., Wells, J. A.
(2004). Mechanistic Diversity of Cytokine Receptor Signaling Across Cell Membranes. Sci Signal
2004: re7-re7
[Abstract] [Full Text] -
Ibarra, C., Estrada, M., Carrasco, L., Chiong, M., Liberona, J. L., Cardenas, C., Diaz-Araya, G., Jaimovich, E., Lavandero, S.
(2004). Insulin-like Growth Factor-1 Induces an Inositol 1,4,5-Trisphosphate-dependent Increase in Nuclear and Cytosolic Calcium in Cultured Rat Cardiac Myocytes. J. Biol. Chem.
279: 7554-7565
[Abstract] [Full Text] -
George, S., Johansen, A., Soos, M. A., Mortensen, H., Gammeltoft, S., Saudek, V., Siddle, K., Hansen, L., O'Rahilly, S.
(2003). Deletion of V335 from the L2 Domain of the Insulin Receptor Results in a Conformationally Abnormal Receptor That Is Unable to Bind Insulin and Causes Donohue's Syndrome in a Human Subject. Endocrinology
144: 631-637
[Abstract] [Full Text]
